Summary

Introduction to Dural Adhesive Agent for Surgical Market

Dural adhesive agent for surgical market is experiencing significant growth, propelled by increasing prevalence of neurological disorders, growing aging population, and echnological advancements in neurosurgical techniques. Considering the optimistic scenario the market is valued at $189.3 million in 2024 and is expected to grow at a CAGR of 5.35% to reach $318.8 million by 2034.

Despite these positive drivers, the market faces hurdles such as complexity of dural repair. However, advances in biomaterials, tissue engineering, and adhesive technologies along with expanding global market for neurosurgical procedures, present lucrative opportunities for the expansion of dural adhesive agent for surgical demand, suggesting a vibrant future for this market as it navigates through challenges towards budgetary constraints and cost pressures as it perceived as more expensive than conventional surgical techniques.

North America experiences a significant burden of neurological disorders, including traumatic brain injuries, brain tumors, and spinal cord injuries. The growing prevalence of these conditions drives the demand for neurosurgical interventions, including the use of dural adhesive agents for repairing dural defects. North America, particularly the U.S. and Canada, has advanced healthcare infrastructure and access to specialized medical services. Brain surgery is relatively common in North America due to the presence of numerous neurosurgical centers and a high prevalence of neurological disorders such as brain tumors, epilepsy, and cerebrovascular diseases.

The trend towards minimally invasive surgery (MIS) techniques in neurosurgery has influenced the demand for dural adhesive agents that are compatible with these approaches. Manufacturers are developing adhesives specifically designed for use in minimally invasive procedures, offering formulations that facilitate precise application and effective dural closure through small incisions or access ports. For instance, in March 2024, a team of researchers, spearheaded by Wyss Institute Founding Core Faculty members, showcased the superior performance of their ""Dural Tough Adhesive"" (DTA) compared to existing surgical sealants. This assertion was substantiated through testing utilizing in vivo animal models and human-derived tissues ex vivo. These findings have been documented and published in Science Translational Medicine. Hydrogels are emerging as promising materials for dural adhesive applications due to their biocompatibility, flexibility, and adhesive properties. Hydrogel-based dural adhesives can conform to irregular tissue surfaces, providing effective sealing and dural repair. Researchers are exploring novel hydrogel formulations with tunable properties for enhanced performance in neurosurgical applications.

Market Segmentation:

Segmentation 1: by Application
• Cranial Surgery
• Spinal Surgery

Segmentation 2: by Type
• Polyethylene glycol
• Others (Fibrin Glue)

Segmentation 3: by Form
• Sealant Glue
• Sealant Film

Segmentation 4: by Region
• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

How can this report add value to an organization?

Product/Innovation Strategy: The global dural adhesive agent for surgical market has been extensively segmented based on various categories, such as application, type, and form. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: A detailed competitive benchmarking of the players operating in the global dural adhesive agent for surgical market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent companies in this market are:

• Integra LifeSciences Corporation
• Covidien (Medtronic)
• Baxter
• Johnson & Johnson MedTech

Key Questions Answered in this Report:

• What are the main factors driving the demand for dural adhesive agent for surgical market?
• What are the major patents filed by the companies active in the dural adhesive agent for surgical market?
• Who are the key players in the dural adhesive agent for surgical market, and what are their respective market shares?
• What partnerships or collaborations are prominent among stakeholders in the dural adhesive agent for surgical market?
• What are the strategies adopted by the key companies to gain a competitive edge in dural adhesive agent for surgical market?
• What is the futuristic outlook for the dural adhesive agent for surgical market in terms of growth potential?
• What is the current estimation of the dural adhesive agent for surgical market, and what growth trajectory is projected from 2024 to 2034?
• Which application, and product segment is expected to lead the market over the forecast period (2024-2034)?
• Which regions demonstrate the highest adoption rates for dural adhesive agent for surgical market, and what factors contribute to their leadership?

ページTOPに戻る

Table of Contents

Executive Summary
Scope and Definition
1. Market: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.1.1 Trends: Overview
1.1.2 Advancements In Surgical Technologies
1.1.3 Increasing Demand for Single-Use Disposable Medical Products
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.3 Research and Development Review
1.3.1 Patent Filing Trend by Country and by Company
1.4 Regulatory Landscape
1.5 Impact Analysis for Key Global Events- COVID-19, Russia/Ukraine or Middle East Crisis on Dural Adhesive Agent for Surgical Market
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities
2. Application
2.1 Application Segmentation
2.2 Application Summary
2.3 Dural Adhesive Agent for Surgical Market (by Application)
2.3.1 Cranial Surgery
2.3.2 Spinal Surgery
3. Product
3.1 Product Segmentation
3.2 Product Summary
3.3 Dural Adhesive Agent for Surgical Market (by Type)
3.3.1 Polyethylene glycol
3.3.2 Others (Fibrin Glue)
3.4 Dural Adhesive Agent for Surgical Market (by Form)
3.4.1 Sealant Glue
3.4.2 Sealant Film
4. Region
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 North America Dural Adhesive Agent for Surgical Market (by Country)
4.3.6.1 U.S.
4.3.6.1.1 Market by Application
4.3.6.1.2 Market by Product
4.3.6.2 Canada
4.3.6.3 Mexico
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 Europe Dural Adhesive Agent for Surgical Market (by Country)
4.4.6.1 Germany
4.4.6.1.1 Market by Application
4.4.6.1.2 Market by Product
4.4.6.2 France
4.4.6.3 U.K.
4.4.6.4 Spain
4.4.6.5 Rest-of-Europe
4.5 Asia-Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 Asia-Pacific Dural Adhesive Agent for Surgical Market (by Country)
4.5.6.1 China
4.5.6.1.1 Market by Application
4.5.6.1.2 Market by Product
4.5.6.2 Japan
4.5.6.3 South Korea
4.5.6.4 Rest-of-Asia-Pacific
4.6 Rest-of-the-World
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
4.6.6 Rest-of-the-World Dural Adhesive Agent for Surgical Market (by Region)
4.6.6.1 South America
4.6.6.1.1 Market by Application
4.6.6.1.2 Market by Product
4.6.6.2 Middle East and Africa
5. Markets - Competitive Landscape & Company Profiles
5.1 Next Frontiers
5.2 Geographic Assessment
5.3 Company Profiles
5.3.1 Medprin
5.3.1.1 Overview
5.3.1.2 Top Products / Product Portfolio
5.3.1.3 Top Competitors
5.3.1.4 Target Customers/End-Users
5.3.1.5 Key Personnel
5.3.1.6 Analyst View
5.3.1.7 Market Share
5.3.2 Integra LifeSciences Corporation
5.3.2.1 Overview
5.3.2.2 Top Products / Product Portfolio
5.3.2.3 Top Competitors
5.3.2.4 Target Customers/End-Users
5.3.2.5 Key Personnel
5.3.2.6 Analyst View
5.3.2.7 Market Share
5.3.3 Pramand, LLC (CraniSeal)
5.3.3.1 Overview
5.3.3.2 Top Products / Product Portfolio
5.3.3.3 Top Competitors
5.3.3.4 Target Customers/End-Users
5.3.3.5 Key Personnel
5.3.3.6 Analyst View
5.3.3.7 Market Share
5.3.4 Stryker
5.3.4.1 Overview
5.3.4.2 Top Products / Product Portfolio
5.3.4.3 Top Competitors
5.3.4.4 Target Customers/End-Users
5.3.4.5 Key Personnel
5.3.4.6 Analyst View
5.3.4.7 Market Share
5.3.5 DuraStat, Inc.
5.3.5.1 Overview
5.3.5.2 Top Products / Product Portfolio
5.3.5.3 Top Competitors
5.3.5.4 Target Customers/End-Users
5.3.5.5 Key Personnel
5.3.5.6 Analyst View
5.3.5.7 Market Share
5.3.6 Covidien (Medtronic)
5.3.6.1 Overview
5.3.6.2 Top Products / Product Portfolio
5.3.6.3 Top Competitors
5.3.6.4 Target Customers/End-Users
5.3.6.5 Key Personnel
5.3.6.6 Analyst View
5.3.6.7 Market Share
5.3.7 Becton
5.3.7.1 Overview
5.3.7.2 Top Products / Product Portfolio
5.3.7.3 Top Competitors
5.3.7.4 Target Customers/End-Users
5.3.7.5 Key Personnel
5.3.7.6 Analyst View
5.3.7.7 Market Share
5.3.8 Regenity
5.3.8.1 Overview
5.3.8.2 Top Products / Product Portfolio
5.3.8.3 Top Competitors
5.3.8.4 Target Customers/End-Users
5.3.8.5 Key Personnel
5.3.8.6 Analyst View
5.3.8.7 Market Share
5.3.9 Baxter
5.3.9.1 Overview
5.3.9.2 Top Products / Product Portfolio
5.3.9.3 Top Competitors
5.3.9.4 Target Customers/End-Users
5.3.9.5 Key Personnel
5.3.9.6 Analyst View
5.3.9.7 Market Share
5.3.10 Johnson & Johnson MedTech
5.3.10.1 Overview
5.3.10.2 Top Products / Product Portfolio
5.3.10.3 Top Competitors
5.3.10.4 Target Customers/End-Users
5.3.10.5 Key Personnel
5.3.10.6 Analyst View
5.3.10.7 Market Share
6. Research Methodology

Press Release